GB breaststroke champion saved by Covid-friendly wonder drug after devastating diagnosis; After an incurable, stage-four lung cancer diagnosis, Karen Huizer is on a trial of new drug lorlatinib. The tablets are an alternative to chemotherapy, which target and shrink tumours

MLA

“GB Breaststroke Champion Saved by Covid-Friendly Wonder Drug after Devastating Diagnosis; After an Incurable, Stage-Four Lung Cancer Diagnosis, Karen Huizer Is on a Trial of New Drug Lorlatinib. The Tablets Are an Alternative to Chemotherapy, Which Target and Shrink Tumours.” Daily Mirror (London, England), 13 Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.682360748&authtype=sso&custid=ns315887.

APA

GB breaststroke champion saved by Covid-friendly wonder drug after devastating diagnosis; After an incurable, stage-four lung cancer diagnosis, Karen Huizer is on a trial of new drug lorlatinib. The tablets are an alternative to chemotherapy, which target and shrink tumours. (2021, November 13). Daily Mirror (London, England).

Chicago

Daily Mirror (London, England). 2021. “GB Breaststroke Champion Saved by Covid-Friendly Wonder Drug after Devastating Diagnosis; After an Incurable, Stage-Four Lung Cancer Diagnosis, Karen Huizer Is on a Trial of New Drug Lorlatinib. The Tablets Are an Alternative to Chemotherapy, Which Target and Shrink Tumours,” November 13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.682360748&authtype=sso&custid=ns315887.